Matches in SemOpenAlex for { <https://semopenalex.org/work/W4386748421> ?p ?o ?g. }
- W4386748421 endingPage "14049" @default.
- W4386748421 startingPage "14049" @default.
- W4386748421 abstract "We tested a hypothesis that in silico-discovered compounds targeting traumatic brain injury (TBI)-induced transcriptomics dysregulations will mitigate TBI-induced molecular pathology and augment the effect of co-administered antiseizure treatment, thereby alleviating functional impairment. In silico bioinformatic analysis revealed five compounds substantially affecting TBI-induced transcriptomics regulation, including calpain inhibitor, chlorpromazine, geldanamycin, tranylcypromine, and trichostatin A (TSA). In vitro exposure of neuronal-BV2-microglial co-cultures to compounds revealed that TSA had the best overall neuroprotective, antioxidative, and anti-inflammatory effects. In vivo assessment in a rat TBI model revealed that TSA as a monotherapy (1 mg/kg/d) or in combination with the antiseizure drug levetiracetam (LEV 150 mg/kg/d) mildly mitigated the increase in plasma levels of the neurofilament subunit pNF-H and cortical lesion area. The percentage of rats with seizures during 0-72 h post-injury was reduced in the following order: TBI-vehicle 80%, TBI-TSA (1 mg/kg) 86%, TBI-LEV (54 mg/kg) 50%, TBI-LEV (150 mg/kg) 40% (p < 0.05 vs. TBI-vehicle), and TBI-LEV (150 mg/kg) combined with TSA (1 mg/kg) 30% (p < 0.05). Cumulative seizure duration was reduced in the following order: TBI-vehicle 727 ± 688 s, TBI-TSA 898 ± 937 s, TBI-LEV (54 mg/kg) 358 ± 715 s, TBI-LEV (150 mg/kg) 42 ± 64 (p < 0.05 vs. TBI-vehicle), and TBI-LEV (150 mg/kg) combined with TSA (1 mg/kg) 109 ± 282 s (p < 0.05). This first preclinical intervention study on post-TBI acute seizures shows that a combination therapy with the tissue recovery enhancer TSA and LEV was safe but exhibited no clear benefit over LEV monotherapy on antiseizure efficacy. A longer follow-up is needed to confirm the possible beneficial effects of LEV monotherapy and combination therapy with TSA on chronic post-TBI structural and functional outcomes, including epileptogenesis." @default.
- W4386748421 created "2023-09-15" @default.
- W4386748421 creator A5000555447 @default.
- W4386748421 creator A5044627303 @default.
- W4386748421 creator A5051493682 @default.
- W4386748421 creator A5059163796 @default.
- W4386748421 creator A5066663995 @default.
- W4386748421 creator A5070165256 @default.
- W4386748421 creator A5070856983 @default.
- W4386748421 creator A5082600086 @default.
- W4386748421 creator A5091914497 @default.
- W4386748421 date "2023-09-13" @default.
- W4386748421 modified "2023-10-17" @default.
- W4386748421 title "Treatment of Status Epilepticus after Traumatic Brain Injury Using an Antiseizure Drug Combined with a Tissue Recovery Enhancer Revealed by Systems Biology" @default.
- W4386748421 cites W145505251 @default.
- W4386748421 cites W1519393156 @default.
- W4386748421 cites W1557124033 @default.
- W4386748421 cites W1563624749 @default.
- W4386748421 cites W1823816085 @default.
- W4386748421 cites W1856441517 @default.
- W4386748421 cites W1896206937 @default.
- W4386748421 cites W1941013676 @default.
- W4386748421 cites W1964328737 @default.
- W4386748421 cites W1964826325 @default.
- W4386748421 cites W1973559709 @default.
- W4386748421 cites W1975508166 @default.
- W4386748421 cites W1976422798 @default.
- W4386748421 cites W1977263445 @default.
- W4386748421 cites W1983635597 @default.
- W4386748421 cites W1984035490 @default.
- W4386748421 cites W1996135664 @default.
- W4386748421 cites W1998783557 @default.
- W4386748421 cites W2004770795 @default.
- W4386748421 cites W2005728257 @default.
- W4386748421 cites W2007191899 @default.
- W4386748421 cites W2008657247 @default.
- W4386748421 cites W2011484579 @default.
- W4386748421 cites W2017688638 @default.
- W4386748421 cites W2021497304 @default.
- W4386748421 cites W2025067370 @default.
- W4386748421 cites W2027144452 @default.
- W4386748421 cites W2032951220 @default.
- W4386748421 cites W2034420564 @default.
- W4386748421 cites W2038636182 @default.
- W4386748421 cites W2039787383 @default.
- W4386748421 cites W2045815014 @default.
- W4386748421 cites W2049268352 @default.
- W4386748421 cites W2051600991 @default.
- W4386748421 cites W2052239635 @default.
- W4386748421 cites W2052408989 @default.
- W4386748421 cites W2052473688 @default.
- W4386748421 cites W2058365710 @default.
- W4386748421 cites W2059799391 @default.
- W4386748421 cites W2068650460 @default.
- W4386748421 cites W2077927847 @default.
- W4386748421 cites W2097545500 @default.
- W4386748421 cites W2103946141 @default.
- W4386748421 cites W2107542208 @default.
- W4386748421 cites W2111843532 @default.
- W4386748421 cites W2113615687 @default.
- W4386748421 cites W2116116157 @default.
- W4386748421 cites W2121106136 @default.
- W4386748421 cites W2125249259 @default.
- W4386748421 cites W2138132463 @default.
- W4386748421 cites W2146373526 @default.
- W4386748421 cites W2146641565 @default.
- W4386748421 cites W2162390271 @default.
- W4386748421 cites W2166326266 @default.
- W4386748421 cites W2191889272 @default.
- W4386748421 cites W2272830106 @default.
- W4386748421 cites W2292895533 @default.
- W4386748421 cites W2298601289 @default.
- W4386748421 cites W2378136745 @default.
- W4386748421 cites W2394586594 @default.
- W4386748421 cites W2406180991 @default.
- W4386748421 cites W2419154990 @default.
- W4386748421 cites W2517794244 @default.
- W4386748421 cites W2519554817 @default.
- W4386748421 cites W2571288670 @default.
- W4386748421 cites W2573888969 @default.
- W4386748421 cites W2574652423 @default.
- W4386748421 cites W2736002996 @default.
- W4386748421 cites W2744012576 @default.
- W4386748421 cites W2748455576 @default.
- W4386748421 cites W2756815751 @default.
- W4386748421 cites W2757318787 @default.
- W4386748421 cites W2766429477 @default.
- W4386748421 cites W2767813783 @default.
- W4386748421 cites W2767903781 @default.
- W4386748421 cites W2774594059 @default.
- W4386748421 cites W2797431873 @default.
- W4386748421 cites W2805677861 @default.
- W4386748421 cites W2871293796 @default.
- W4386748421 cites W2902315624 @default.
- W4386748421 cites W2905302554 @default.
- W4386748421 cites W2905464475 @default.
- W4386748421 cites W2910022329 @default.
- W4386748421 cites W2929652033 @default.